Invention Grant
- Patent Title: Liraglutide in cardiovascular conditions
-
Application No.: US15401651Application Date: 2017-01-09
-
Publication No.: US09968659B2Publication Date: 2018-05-15
- Inventor: Soeren Rasmussen
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Leon Y. Lum
- Priority: EP16158739 20160304; EP16173917 20160610; EP16001329 20160613
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61P3/10 ; A61P7/12 ; C07K14/605
Abstract:
The present invention relates to the GLP-1 receptor agonist liraglutide for use in medicine.
Public/Granted literature
- US20170252408A1 Liraglutide In Cardiovascular Conditions Public/Granted day:2017-09-07
Information query
IPC分类:
